NEW CPD accredited education
is now available on the Australian
College of Pharmacy website,
offering pharmacists the
opportunity to improve their
knowledge about neuropathic
pain associated with postherpetic
neuralgia (PHN), as well as outlining
the effective treatment options.
The online module, titled Treating
and preventing postherpetic
neuralgia, also discusses the role
of pharmacists in identifying,
managing and treating patients
with PHN.
Pharmacists who complete
the education and the relevant
assessment will receive 4.0 Group 2
CPD credits.
To access the program, go to
www.acp.edu.au.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Apr 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Apr 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.